Top 29 Cytos investors
The most complete profiles first. Showing 29 of 29.
Chris JacksonVerified
Venture Capital, Investor · United States
SeedHealth CareE-commerceWomen FoundedLife SciencePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Verified email available
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Richard GasterVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Verified email available
Sunny ReddyVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Aftab KheraniVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Andrew SchiffVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more
Verified email available
David PezeshkiVerified
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Verified email available
Eric AguiarVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Jason DoddVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Josh BilenkerVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Keith UnderwoodVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Verified email available
Robert WenzelVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Aaron Royston, M.D.
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more
Contact details available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Jaume Pons
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Per Samuelsson
Venture Capital, Private Equity Firm, Investor · Sweden
SeedHealth CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Staffan Lindstrand
Venture Capital, Private Equity Firm, Investor · Sweden
SeedHealth CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Yvonne Yamanaka
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Nikki Matthews
Venture Capital · United States
Health CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Scott Braunstein
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
Sophie Phillips
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Cytos investors are on Angel Roster?
Angel Roster lists 29 Cytos investors. 14 of them (48%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (27), Private Equity Firms (19) and Advisor Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Cytos investors invest in?
Among those that list a stage, the most common are Series B (10) and Seed (4).
Where are Cytos investors based?
Most are based in the United States (22), the United Kingdom (5) and Sweden (2).
Which companies have Cytos investors backed?
The most-backed portfolio companies among them are Spruce Biosciences (24), Verona Pharma (18), Paratek Pharmaceuticals (18), GTx (18) and Reneo Pharmaceuticals (18).
How do I contact Cytos investors?
Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.